Literature DB >> 2703306

Feasibility of blood flow measurement by externally controlled dye delivery.

R C Zeimer1, B Khoobehi, G Peyman, M R Niesman, R L Magin.   

Abstract

We are developing a new method of delivering substances locally and repeatedly in the retinal vasculature under external control. This delivery system is based on encapsulating the substance in heat-sensitive lipsomes, which are injected intravenously and lysed by a heat pulse delivered by a laser. The feasibility of using this system with dyes and creating a sharp dye front was tested in vitro and in vivo. The results indicate that the background fluorescence of intact liposomes is minimal but in contrast a dramatic increase in fluorescence is achieved where the dye is released. In vivo tests indicated that only the selected vascular branch fluoresced. Moreover, a sharp dye front could be obtained repeatedly and preserved over significant distances. The presence of a sharp dye front allowed measurements, in vitro, of blood velocity which correlated well (r = 0.985, P less than 0.001) with the average blood velocity values calculated from the known flow rate.

Mesh:

Substances:

Year:  1989        PMID: 2703306

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  The principle of retinal rheometry.

Authors:  P R Preussner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

2.  Feasibility of laser targeted photo-occlusion of ocular vessels.

Authors:  S Asrani; R Zeimer
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

Review 3.  Ocular blood flow measurement.

Authors:  T H Williamson; A Harris
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

4.  Occlusion of retinal vessels using targeted delivery of a platelet aggregating agent.

Authors:  Y Ogura; T Guran; K Takahashi; R Zeimer
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.